EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors
Clinical trial NCT06541639 · RECRUITING
Trial details
- NCT number
- NCT06541639
- Sponsor
- Peking University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-04
- Primary completion
- 2028-03-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.